Mechanisms of resistance to alkylating agents

G Damia1, M D'Incalci

  • 1Department of Oncology, Instituto di Ricerche Farmacologiche 'Mario Negri', Via Eritrea 62, 20157, Milan, Italy., deponcol@irfmn.mnegri.it.

Cytotechnology
|November 13, 2008
PubMed

Insights

Alkylating agents target DNA in cancer treatment, but resistance limits efficacy. This review details how cells evade these drugs through pre-target (drug inactivation) and post-target (DNA repair) mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Alkylating agents are crucial anticancer drugs targeting DNA.
  • Drug resistance is a major obstacle in cancer chemotherapy.
  • The precise mechanisms of DNA lesion-induced cell death remain unclear.

Purpose of the Study:

  • To review characterized mechanisms of resistance to alkylating agents.
  • To differentiate between pre- and post-target resistance strategies.
  • To discuss the role of cellular systems in modulating drug efficacy.

Main Methods:

  • Literature review of established resistance mechanisms.
  • Categorization of resistance into pre- and post-target pathways.
  • Examination of specific cellular components involved in resistance.

Main Results:

  • Pre-target mechanisms limit DNA adduct formation via reduced drug uptake or enhanced detoxification (e.g., DT-diaphorase, metallothionein, GST/GSH).
  • Post-target mechanisms involve DNA repair pathways, damage tolerance, and downstream effects like cell cycle arrest and apoptosis.
  • Various cellular systems contribute to resistance against alkylating agents.

Conclusions:

  • Understanding resistance mechanisms is vital for improving cancer treatment outcomes.
  • Both limiting drug-target interaction and enhancing cellular repair/tolerance are key resistance strategies.
  • Further research into these mechanisms can guide the development of more effective therapies.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...